Inventor
LIU ZHONGHAO
US10 patents
Patents
10 patentsUS10961315B2Mar 30, 2021
Method of treating type I diabetes by administering a combination of a glucagon receptor antagonist and an anti-CD3 antibody
NGM BIOPHARMACEUTICALS INC5 citations81
US10995145B2May 4, 2021
Antibodies which bind human glucagon receptor
NGM BIOPHARMACEUTICALS INC2 citations72
US10774139B2Sep 15, 2020
ANGPTL8-binding agents and methods of use thereof
NGM BIOPHARMACEUTICALS INC3 citations70
US11136381B2Oct 5, 2021
Anti-C3 antibodies
NGM BIOPHARMACEUTICALS INC3 citations69
US10702587B2Jul 7, 2020
Angiopoietin-like protein 8 polypeptide fragments and compositions thereof
NGM BIOPHARMACEUTICALS INC1 citations68
US10071139B2Sep 11, 2018
Methods for treatment of conditions associated with elevated triglycerides with an ANGPTL8 polypeptide fragment
NGM BIOPHARMACEUTICALS INC3 citations68
US11732049B2Aug 22, 2023
Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor
NGM BIOPHARMACEUTICALS INC0 citations62
US11845802B2Dec 19, 2023
Combination therapy with a glucagon receptor (GCGR) antibody and an anti-CD3 antibody
NGM BIOPHARMACEUTICALS INC0 citations60
US11767359B2Sep 26, 2023
C3-binding agents and methods of use thereof
NGM BIOPHARMACEUTICALS INC0 citations59
US11566067B2Jan 31, 2023
Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or antigen-binding fragment thereof
NGM BIOPHARMACEUTICALS INC0 citations59